For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

AI adoption is an organizational design problem, not a technology procurement challenge. The question every founder and ...

VC increased their spending in university spinoffs, and in later rounds of US companies spun out from academia, PitchBook ...

In the pursuit of powering artificial intelligence (AI) and the race to come out on top, data has become the new oil. Companies that control the pipelines are pulling in record venture capital (VC), ...

When software becomes trivially cheap to build, defensibility shifts to what takes years to accumulate — data, networks, ...

In light of OpenAI’s expectation that AI superintelligence will profoundly reshape the world, the company released a 13-page industrial policy memo of its own ideas to tackle the coming transition.

Why is old exon science getting new traction? What’s unsettling biotech VCs? And who will be the next CEO of PhRMA?

It is the path of least resistance for a growth-stage company to hire from the familiar Silicon Valley pipelines but if a ...

VCs are increasingly buying shares of late-stage startups on the secondary market as they try to get pieces of the hottest ones — especially AI companies. But they are also increasingly doing so ...

Sustainability tech has been all the buzz in the last few years. Investors are hunting promising ESG businesses, governments are pushing ambitious legislation, and companies are getting on board to ...

Indian mid-stage startups are seeing significant valuation surges despite a broader funding slowdown, indicating a ...